DELAINE GOLSON: Open Payments
NPI 1124584719 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$48 in 2 payments from 2 companies in 2025. Trend: 2023 $121 · 2024 $222 · 2025 $48
Food & beverage: $48
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $29 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
Products named: INGREZZA, NUPLAZID.
Industry payments across LA — which companies pay providers there.
